Literature DB >> 4341998

The influence of the route of immunization on the protection of mice infected intracerebrally with Bordetella pertussis.

A F Standfast, J M Dolby.   

Abstract

The development of immunity in mice to Bordetella pertussis induced by intracerebral, intravenous or intraperitoneal vaccination was analysed in terms of the viable bacteria in the brain after intracerebral challenge, the serum antibodies, and protection against the sublethal infection of the lung that follows intranasal inoculation.A vaccine introduced intracerebrally was five to ten times more effective than that given intraperitoneally or intravenously, as measured for each route by the amount of vaccine required to protect half the mice against an intracerebral challenge 14 days later (ImD 50). Intracerebral vaccination induced higher antibody titres than vaccination by the other two routes. The survival of infected mice given 1-3 ImD 50 doses of vaccine intracerebrally 14 days before, followed a pattern similar to that after intraperitoneal or intravenous vaccination with up to 10 ImD 50 of vaccine: the numbers of organisms increased for 3 days and then declined. Injection of about four ImD 50 of vaccine intracerebrally produced a local immunity, resulting in an immediate kill of challenge organisms given 14 days later. Such an effect following intraperitoneal vaccination was achieved only against challenges with an avirulent strain. It is suggested that better stimulation of circulating antibody and local immunity in the brain together account for the better protection induced by intracerebral vaccine.Immunity to an intracerebral infection appears therefore to have at least three components, each specific for pertussis. The first, like that induced by intraperitoneal and intravenous vaccination, reaches a maximum in 2 or 3 weeks and is probably an expression of a general response by the animal operating not earlier than 3 days after infection. The second is a local immunity, appearing after the same interval. The third is a short-lived local immunity which has been described by previous workers; it immediately follows the injection intracerebrally of ten times less vaccine than that needed to protect against a challenge 14 days later and lasts only 2-3 days. The second and third types result in immediate sterilization of the infection.Mice recovering from sublethal brain infection with avirulent organisms were immune to a second infection with a virulent organism, but this was achieved not by the ability to kill the re-infecting organisms immediately on injection into the brain, but only after the 3-4 days lag such as follows intraperitoneal vaccination.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341998      PMCID: PMC2130195          DOI: 10.1017/s0022172400063075

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  16 in total

1.  Immunity in mice to an intracerebral challenge of Bordetella pertussis.

Authors:  L B HOLT; V SPASOJEVIC; J M DOLBY; A F STANDFAST
Journal:  J Hyg (Lond)       Date:  1961-09

2.  Interference immunity produced by pertussis vaccine to pertussis infection in mice.

Authors:  D G EVANS; F T PERKINS
Journal:  Br J Exp Pathol       Date:  1954-12

3.  The production of both interference and antibody immunity by pertussis vaccine to pertussis infection in mice.

Authors:  D G EVANS; F T PERKINS
Journal:  Br J Exp Pathol       Date:  1955-08

4.  The ability of pertussis vaccine to produce in mice specific immunity of a type not associated with antibody production.

Authors:  D G EVANS; F T PERKINS
Journal:  Br J Exp Pathol       Date:  1954-08

5.  Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge.

Authors:  P L Kendrick; G Eldering; M K Dixon; J Misner
Journal:  Am J Public Health Nations Health       Date:  1947-07

6.  Intracerebral infection of mice with high-virulence and low-virulence strains of Bordetella pertussis.

Authors:  G J Adams
Journal:  J Med Microbiol       Date:  1970-02       Impact factor: 2.472

7.  The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.

Authors:  J M Dolby; D E Dolby
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

8.  The antibacterial effect of Bordetella pertussis antisera.

Authors:  J M Dolby
Journal:  Immunology       Date:  1965-05       Impact factor: 7.397

9.  Intracerebral mouse protection test for petussis vaccine. II. Immunosuppression with cyclophosphamide.

Authors:  H E Blake; A C Wardlaw
Journal:  Can J Microbiol       Date:  1969-12       Impact factor: 2.419

10.  Characterization of the antibodies responsible for the 'bactericidal activity patterns' of antisera to Bordetella pertussis.

Authors:  J M Dolby; W A Vincent
Journal:  Immunology       Date:  1965-05       Impact factor: 7.397

View more
  3 in total

1.  The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice.

Authors:  J M Dolby; D E Dolby; C J Bronne-Shanbury
Journal:  J Hyg (Lond)       Date:  1975-02

2.  The effect of the antigen which elicits the bactericidal antibody and of the mouse-protective antigen on the growth of Bordetella pertussis in the mouse brain.

Authors:  J M Dolby; J P Ackers; D E Dolby
Journal:  J Hyg (Lond)       Date:  1975-02

3.  Passive protection of mice against intracerebral infections with Bordetella pertussis.

Authors:  J M Dolby
Journal:  J Hyg (Lond)       Date:  1972-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.